Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
At baseline, the mean AHI was 51.5 in trial 1 and 49.5 in trial 2
Localized instillation enables in vivo screening of targeting peptides using one-bead one-compound technology
BPC-157 research compound is supplied to qualified research laboratories, academic institutions, and analytical facilities sourcing materials for in-vitro and preclinical studies
Other endpoints included changes from baseline in waist circumference, abdominal subcutaneous tissue (SAT), trunk fat, and lean body mass
The combination can significantly reduce appetite and caloric intake, which, if not carefully managed, may lead to dehydration, fatigue, or low blood pressure particularly in individuals also taking antihypertensive medications
US$ 23.29
US$ 21.35
US$ 26.19
US$ 29.13
US$ 28.00
US$ 27.90
